Profile data is unavailable for this security.
About the company
IO Biotech Inc is a clinical-stage biopharmaceutical company developing immune-modulating cancer therapies based on T-win technology platform. The Company’s product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression. IO Biotech’s lead product candidate, IO102-IO103, is designed to target the immunosuppressive mechanisms mediated by key immunosuppressive proteins such as IDO and PD-L1. The Company develops a pipeline of product candidates that leverage its T-win technology platform to address targets within the TME. The Company is spin-off of National Cancer for Center Immune Therapy at Herlev University Hospital in Denmark.
- Revenue in USD (TTM)0.00
- Net income in USD-88.50m
- Incorporated2021
- Employees68.00
- LocationIO Biotech IncOle Maaloes Veh 3COPENHAGEN 2200DenmarkDNK
- Websitehttps://www.iobiotech.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MDxHealth SA - ADR | 75.33m | -39.90m | 78.59m | 300.00 | -- | -- | -- | 1.04 | -1.14 | -1.14 | 0.8428 | -0.0357 | 0.5528 | 11.06 | 6.95 | 251,090.00 | -29.28 | -51.62 | -33.98 | -64.72 | 62.76 | 50.88 | -52.97 | -117.64 | 1.53 | -1.54 | 1.02 | -- | 89.43 | 19.84 | 2.14 | -- | 30.13 | -- |
Gritstone bio Inc | 15.65m | -144.89m | 79.72m | 231.00 | -- | 5.16 | -- | 5.10 | -1.57 | -1.57 | 0.17 | 0.1423 | 0.0901 | -- | 40.53 | 67,727.27 | -83.47 | -48.08 | -97.70 | -55.18 | -- | -- | -926.13 | -573.71 | -- | -554.88 | 0.7428 | -- | -18.05 | 68.96 | -15.71 | -- | -4.19 | -- |
Cognition Therapeutics Inc | 0.00 | -28.77m | 80.12m | 25.00 | -- | 2.77 | -- | -- | -0.9155 | -0.9155 | 0.00 | 0.7218 | 0.00 | -- | -- | 0.00 | -68.08 | -- | -85.18 | -- | -- | -- | -- | -- | -- | -251.59 | 0.00 | -- | -- | -- | -20.52 | -- | -- | -- |
Cue Biopharma Inc | 7.02m | -49.97m | 80.26m | 53.00 | -- | 2.67 | -- | 11.43 | -1.07 | -1.07 | 0.1495 | 0.6175 | 0.1035 | -- | 8.80 | 132,452.80 | -73.69 | -57.45 | -96.35 | -68.41 | -- | -- | -711.84 | -810.87 | -- | -- | 0.1935 | -- | 340.88 | 36.88 | 4.30 | -- | -- | -- |
IO Biotech Inc | 0.00 | -88.50m | 80.37m | 68.00 | -- | 0.6961 | -- | -- | -1.86 | -1.86 | 0.00 | 1.75 | 0.00 | -- | -- | 0.00 | -66.79 | -- | -72.66 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -20.47 | -- | -- | -- |
Milestone Pharmaceuticals Inc | 0.00 | -55.09m | 80.42m | 47.00 | -- | 2.01 | -- | -- | -1.25 | -1.25 | 0.00 | 0.7498 | 0.00 | -- | -- | 0.00 | -53.21 | -48.44 | -56.51 | -51.56 | -- | -- | -- | -1,267.25 | -- | -- | 0.5592 | -- | -80.00 | -- | -2.22 | -- | 86.23 | -- |
Angion Biomedica Corp | 0.00 | -38.99m | 80.83m | 32.00 | -- | 16.52 | -- | -- | -6.63 | -6.63 | 0.00 | 0.4765 | 0.00 | -- | -- | 0.00 | -117.72 | -105.91 | -133.85 | -331.69 | -- | -- | -- | -712.81 | -- | -- | 0.00 | -- | -100.00 | -- | 9.31 | -- | -- | -- |
Marinus Pharmaceuticals Inc | 28.29m | -145.34m | 81.30m | 165.00 | -- | -- | -- | 2.87 | -2.64 | -2.64 | 0.5142 | -0.2992 | 0.1554 | 0.8536 | 3.72 | 171,442.40 | -79.82 | -49.64 | -96.93 | -57.76 | 91.22 | -- | -513.80 | -518.96 | 2.93 | -13.62 | 1.29 | -- | 21.63 | -- | -613.59 | -- | 7.47 | -- |
Elutia Inc | 25.05m | -49.46m | 81.57m | 54.00 | -- | -- | -- | 3.26 | -2.35 | -2.34 | 1.24 | -2.07 | 0.5219 | 2.06 | 4.27 | 463,833.30 | -103.05 | -42.93 | -599.50 | -79.34 | 42.01 | 43.32 | -197.48 | -64.16 | 0.5499 | -1.36 | -- | -- | -49.69 | -8.71 | -25.39 | -- | 12.74 | -- |
Anixa Biosciences Inc | 210.00k | -10.74m | 81.98m | 4.00 | -- | 3.32 | -- | 390.39 | -0.3451 | -0.3451 | 0.0068 | 0.7749 | 0.0078 | -- | 0.7807 | 52,500.00 | -40.49 | -59.69 | -41.26 | -62.61 | -- | -- | -5,174.29 | -6,040.10 | -- | -- | 0.00 | -- | -- | -28.36 | 27.83 | -- | -- | -- |
Sellas Life Sciences Group Inc | 0.00 | -35.81m | 82.01m | 16.00 | -- | 8.25 | -- | -- | -1.12 | -1.12 | 0.00 | 0.1721 | 0.00 | -- | -- | 0.00 | -133.77 | -111.48 | -303.59 | -184.29 | -- | -- | -- | -1,289.42 | -- | -- | 0.00 | -- | -100.00 | -- | 9.59 | -- | -- | -- |
Serina Therapeutics Inc | 137.00k | -20.96m | 82.08m | 4.00 | -- | -- | -- | 599.11 | -14.07 | -14.07 | 0.0909 | -0.5121 | 0.0117 | -- | 3.86 | 34,250.00 | -179.27 | -194.46 | -- | -- | 67.88 | 85.80 | -15,301.46 | -2,347.36 | -- | -0.9274 | 1.70 | -- | 317.65 | -36.69 | -41.49 | -- | -- | -- |
Assembly Biosciences Inc | 12.95m | -51.36m | 82.42m | 65.00 | -- | 2.51 | -- | 6.37 | -11.22 | -11.22 | 2.76 | 5.95 | 0.1276 | -- | 34.07 | 199,200.00 | -50.60 | -39.69 | -66.58 | -44.03 | -- | -- | -396.63 | -409.24 | -- | -- | 0.00 | -- | -- | -13.51 | 34.23 | -- | -5.59 | -- |
Holder | Shares | % Held |
---|---|---|
Lundbeckfond Invest A/Sas of 09 Aug 2023 | 13.95m | 21.18% |
HBM Partners AG (Investment Management)as of 31 Dec 2023 | 3.94m | 5.99% |
PFM Health Sciences LPas of 31 Mar 2024 | 2.34m | 3.55% |
Marshall Wace LLPas of 31 Mar 2024 | 2.11m | 3.20% |
Morgan Stanley & Co. LLCas of 31 Mar 2024 | 2.00m | 3.04% |
Armistice Capital LLCas of 31 Mar 2024 | 1.72m | 2.62% |
BofA Securities, Inc.as of 31 Mar 2024 | 1.65m | 2.51% |
Logos Global Management LPas of 31 Mar 2024 | 493.83k | 0.75% |
Fidelity Management & Research Co. LLCas of 31 Mar 2024 | 314.60k | 0.48% |
Morgan Stanley Smith Barney LLC (Investment Management)as of 31 Mar 2024 | 194.35k | 0.30% |